The gene encoding MLL3 histone methyltransferase, KMT2C, promoter methylation of which in plasma cell‐free DNA (cfDNA) was found to can indicate unfortunate results in NSCLC and provide further assessment as a circulating epigenetic biomarker (167). Here, KMT2C is linked to non-small cell lung carcinoma.